madman
Super Moderator
Great news for Canadians!
The first long-acting injectable esterifed T formulation will be available soon!
* Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to Nebido® (testosterone undecanoate), a long-acting injectable therapy indicated for the treatment of male hypogonadism (testosterone deficiency).[1]
searchlightpharma.com
...
The first long-acting injectable esterifed T formulation will be available soon!
* Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to Nebido® (testosterone undecanoate), a long-acting injectable therapy indicated for the treatment of male hypogonadism (testosterone deficiency).[1]
Searchlight Pharma | About
At Searchlight, our global team is committed to changing lives through innovative care, guided by strong values and dedicated leadership.
searchlightpharma.com
